About this trial

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 10 trial groups

10

Trial groups

See each trial group below.

Locations

1
Rossignol Medical Center85050, PhoenixArizona, United States

Sponsors and collaborators

Richard Frye

Lead sponsor

Rossignol Medical Center

Sponsor institution

Autism Discovery and Treatment Foundation

Collaborator